# US 2026/0227379 A1 · Devices and methods for clot burst pressure measurement

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0227379 A1
- Document ID: US20260227379A1
- Status: Published application
- Kind: A1
- Application number: 19/154,013
- Filed: 2024-02-05
- Published: 2026-08-06
- Earliest claimed: 2023-02-07
- Assignees: Board of Regents, The University of Texas System
- Applicants: The Board of Regents of the University of Texas System
- Inventors: Brijesh S. GILL; Atharwa R. MANKAME; Julia LITVINOV; Charles S. COX
- Web page: https://patentgrep.com/patent/US20260227379A1

## CPC

- G01N 33/4905: {Determining clotting time of blood (by chemical methods G01N33/86, C12Q1/56)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Apparatus and methods for clot burst pressure measurement are disclosed herein. Specific embodiments include a pump, a pressure measurement device, and a container comprising an inlet, an outlet and an orifice. In particular embodiments, the pump is coupled to the inlet of the container, the pressure measurement device is coupled to the outlet of the container, and the orifice is configured to retain a fluid extending across the orifice.

## Claims

### Claim 1

An apparatus for measuring clot burst pressure, the apparatus comprising:
a pump;
a pressure measurement device; and
a container comprising an inlet, an outlet and an orifice, wherein:
the pump is coupled to the inlet of the container;
the pressure measurement device is coupled to the outlet of the container; and
the orifice is configured to retain a fluid extending across the orifice.

### Claim 2 (depends on 1)

The apparatus of claim 1 wherein the fluid comprises blood or plasma.

### Claim 3 (depends on 1, 2)

The apparatus of claim 1 or claim 2 wherein the fluid comprises fibrinogen.

### Claim 4 (depends on 1, 2, 3)

The apparatus of any one of claims 1-3 wherein the fluid comprises heparin.

### Claim 5 (depends on 1, 2, 3, 4)

The apparatus of any one of claims 1-4 wherein the fluid comprises platelets.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The apparatus of any one of claims 1-5 wherein the fluid comprises tranexamic acid.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The apparatus of any one of claims 1-6 wherein the fluid comprises thrombin.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The apparatus of any one of claims 1-7 wherein the fluid is coagulated.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The apparatus of any one of claims 1-8 wherein the orifice has a diameter greater than or equal to 0.05 inches and less than or equal to 0.20 inches.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The apparatus of any one of claims 1-9 wherein:
the orifice is a first orifice of a plurality of orifices in the container; and
each orifice in the plurality of orifices is configured to retain the fluid.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The apparatus of any one of claims 1-10 wherein each orifice in the plurality of orifices has a diameter greater than or equal to 0.05 inches and less than or equal to 0.20 inches.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The apparatus of any one of claims 1-11 wherein the pump comprises a syringe.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The apparatus of any one of claims 1-12 wherein the pressure measurement device comprises a column comprising a measurement fluid.

### Claim 14 (depends on 13)

The apparatus of claim 13 wherein the measurement fluid is water.

### Claim 15 (depends on 13)

The apparatus of claim 13 wherein the measurement fluid is saline.

### Claim 16 (depends on 13)

The apparatus of claim 13 wherein the measurement fluid is air.

### Claim 17 (depends on 16)

The apparatus of claim 16 wherein the pressure measurement device comprises an aneroid manometer.

### Claim 18 (depends on 14, 15, 16)

The apparatus of any one of claims 14-16 wherein the pump is configured to pump the measurement fluid from the pump to the container and into the column.

### Claim 19 (depends on 18)

The apparatus of claim 18 wherein the pump is configured to pump the measurement fluid at a rate greater than or equal to 0.2 milliliters per second (mL/s) and less than or equal to 2.5 mL/s.

### Claim 20 (depends on 19)

The apparatus of claim 19 further comprising an indicator of a level of the measurement fluid in the column.

### Claim 21 (depends on 20)

The apparatus of claim 20 wherein the indicator is configured to detect a maximum level of the measurement fluid in the column.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The apparatus of any one of claims 1-21 further comprising:
a first conduit; and
a second conduit, wherein:
the first conduit is coupled to the pump and the inlet to the container; and
the second conduit is coupled to the outlet of the contain and the pressure measurement device.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The apparatus of any one of claims 1-22 wherein a surface around the orifice is chemically actualized.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The apparatus of any one of claims 1-22 wherein a surface around the orifice is coated with collagen.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The apparatus of any one of claims 1-22 wherein a surface around the orifice is coated with fibronectin.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The apparatus of any one of claims 1-22 wherein a surface around the orifice is coated with thrombin.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The apparatus of any one of claims 1-22 wherein a surface around the orifice is coated with fibrinogen.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The apparatus of any one of claims 1-22 wherein a surface around the orifice is coated with freeze-dried platelets or plasma proteins.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The apparatus of any one of claims 1-22 wherein a surface around the orifice is coated with specific factors from a clotting cascade to detect deficiencies in those factors.

### Claim 30 (depends on 23, 24, 25, 26, 27, 28, 29)

The apparatus of any one of claims 23-29 wherein the surface around the orifice includes an indentation.

### Claim 31

A method of measuring clot burst pressure, the method comprising:
applying a fluid across an orifice of a container;
forming a clot from the fluid, wherein the clot extends across the orifice of the container;
increasing a pressure inside the container; and
measuring the pressure inside the container when the clot is dislodged from the orifice.

### Claim 32 (depends on 31)

The method of claim 31 wherein forming the clot comprises:
providing a support surface across the orifice prior to applying the fluid across the orifice;
applying the fluid to the support surface; and
removing the support surface after a period of time.

### Claim 33 (depends on 32)

The method of claim 32 wherein forming the clot further comprises providing a temperature inside the container greater than 25 degrees Celsius prior to removing the support surface.

### Claim 34 (depends on 32)

The method of claim 32 wherein forming the clot further comprises providing a temperature inside the container greater or equal to 35 degrees Celsius and less than or equal to 40 degrees Celsius prior to removing the support surface.

### Claim 35 (depends on 32)

The method of claim 32 wherein forming the clot further comprises providing a temperature inside the container of approximately 37 degrees Celsius prior to removing the support surface.

### Claim 36 (depends on 32, 33, 34, 35)

The method of any one of claims 32-35 wherein the period of time is greater than or equal to 5 minutes and less than or equal to 50 minutes.

### Claim 37 (depends on 36)

The method of claim 36 wherein the time period is approximately 30 minutes.

### Claim 38 (depends on 31, 32, 33, 34, 35, 36, 37)

The method of any one of claims 31-37 wherein forming the clot further comprises adding heparin to the fluid.

### Claim 39 (depends on 31, 32, 33, 34, 35, 36, 37, 38)

The method of any one of claims 31-38 wherein forming the clot further comprises adding fibrinogen to the fluid.

### Claim 40 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39)

The method of any one of claims 31-39 wherein increasing the pressure inside the container comprises pumping a measurement fluid into the container.

### Claim 41 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The method of any one of claims 31-40 wherein measuring the pressure inside the container when the clot is dislodged from the orifice comprises measuring a column of the measurement fluid.
